Related Experiment Video

Updated: Dec 7, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

929

New Insights Into Targeting Membrane Lipids for Cancer Therapy

Giulio Preta1

  • 1Institute of Biochemistry, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Frontiers in Cell and Developmental Biology
|September 28, 2020
PubMed

Insights

Membrane-lipid therapy targets cancer cell membranes by altering lipid composition and biophysical properties. This approach enhances chemotherapy sensitivity and overcomes multidrug resistance in cancer treatment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Plasma membranes possess complex lipid and protein organization, featuring lipid rafts crucial for cellular signaling and response.
  • Differences in lipid composition between healthy and cancer cells offer therapeutic targets.
  • Membrane-lipid therapy leverages these differences for novel cancer treatments.

Purpose of the Study:

  • To explore therapeutic strategies modulating membrane lipid composition and organization for cancer treatment.
  • To investigate methods for enhancing chemotherapy sensitivity and overcoming multidrug resistance in cancer cells.

Main Methods:

  • Reviewing strategies that influence cholesterol and sphingolipid content in cell membranes.
  • Presenting innovative approaches to alter membrane bilayer biophysical properties without changing constituent composition.

Main Results:

  • Targeting membrane lipids can increase cancer cell sensitivity to chemotherapeutic agents.
  • Modulating lipid composition and biophysical properties presents a viable strategy against multidrug resistance.
  • Lipid rafts are key platforms for protein receptors regulating critical cellular functions.

Conclusions:

  • Membrane-lipid therapy is a promising strategy for cancer treatment.
  • Targeting membrane lipids can overcome chemotherapy resistance.
  • Altering membrane biophysical properties offers a novel therapeutic avenue.
Keywords:
amphiphilic moleculescell signalinglipid raftsmembrane fluidityprotein receptors

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.3K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K